 Brokerages predict that Concert Pharmaceuticals Inc NASDAQ:CNCE will announce 10,000.00 in sales for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Concert Pharmaceuticals earnings. Concert Pharmaceuticals posted sales of 50,000.00 in the same quarter last year, which would suggest a negative year over year growth rate of 80. The company ... 